>AT2G32390.1 |  ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel 
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG 
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF 
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES 
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA 
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT 
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY 
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW 
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD 
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP 
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH 
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ 
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN 
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI 
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS 
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.1 |  ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel 
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG 
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF 
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES 
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA 
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT 
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY 
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW 
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD 
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP 
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH 
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ 
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN 
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI 
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS 
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.2 |  ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel 
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ 
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD 
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM 
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV 
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT 
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL 
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI 
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE 
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ 
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI 
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA 
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK 
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP 
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE 
NSQSKDHETPQ*
>AT2G32390.2 |  ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel 
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ 
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD 
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM 
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV 
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT 
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL 
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI 
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE 
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ 
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI 
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA 
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK 
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP 
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE 
NSQSKDHETPQ*
>AT5G51350.1 |  leucine-rich repeat transmembrane protein kinase putative 
MASSKHNKLCSFFYLCLFLTLVAAAEPQTESLLTLKSQLTDNFNSLKDWFINTPEVSDNL 
VACCSWSGVRCNQNSTSVVSVDLSSKNLAGSLSGKEFLVFTELLELNISDNSFSGEFPAE 
IFFNMTNLRSLDISRNNFSGRFPDGNGGDSSLKNLIFLDALSNSFSGPLPIHLSQLENLK 
VLNLAGSYFTGSIPSQYGSFKNLEFLHLGGNLLSGHIPQELGNLTTLTHMEIGYNSYEGV 
IPWEIGYMSELKYLDIAGANLSGFLPKHFSNLTKLESLFLFRNHLSREIPWELGEITSLV 
NLDLSDNHISGTIPESFSGLKNLRLLNLMFNEMSGTLPEVIAQLPSLDTLFIWNNYFSGS 
LPKSLGMNSKLRWVDVSTNSFQGEIPQGICSRGVLFKLILFSNNFTGTLSPSLSNCSTLV 
RIRLEDNSFSGVIPFSFSEIPDISYIDLSRNKLTGGIPLDISKATKLDYFNISNNPELGG 
KLPPHIWSAPSLQNFSASSCSISGGLPVFESCKSITVIELSNNNISGMLTPTVSTCGSLK 
KMDLSHNNLRGAIPSDKVFQSMGKHAYESNANLCGLPLKSCSAYSSRKLVSVLVACLVSI 
LLMVVAALALYYIRQRSQGQWKMVSFAGLPHFTADDVLRSFGSPEPSEAVPASVSKAVLP 
TGITVIVRKIELHDKKKSVVLNVLTQMGNARHVNLVRLLGFCYNNHLVYVLYDNNLHTGT 
TLAEKMKTKKKDWQTKKRIITGVAKGLCFLHHECLPAIPHGDVKSSNILFDDDKIEPCLG 
EFGFKYMLHLNTDQMNDVIRVEKQKDVYNFGQLILEILTNGKLMNAGGLMIQNKPKDGLL 
REVYTENEVSSSDFKQGEVKRVVEVALLCIRSDQSDRPCMEDALRLLSEAENRFK*
>AT2G24710.1 |  ATGLR23 intracellular ligand-gated ion channel 
MRTEKLFFCILLVFFFCLEFNRGQNNGKTLVDVGVVTDVDTSHSKVVMLCINMSISDFYS 
SNPQFETRLVVNVGDSKSDVVGAAIAALDLIKNKQVKAILGPWTSMQAHFLIEIGQKSRV 
PIVSYSATSPILTSLRSPYFLRATYEDSFQVQPIKAIIKLFGWREVVPVYIDNTFGEGIM 
PRLTDALQDINVRIPYRSVIAINATDHEISVELLKMMNMPTRVFLVHMYYDLASRFFIKA 
KELGLMEPGYVWILTNGVIDDLSLINETAVEAMEGVLGIKTYIPKSPDLEKFRSRWRSLF 
PRVELSVYGLWAYDATTALAVAIEEAGTNNMTFSKVVDTGRNVSELEALGLSQFGPKLLQ 
TLLTVQFRGLAGEFRFFRGQLQPSVFEIVNIINTGEKSIGFWKEGNGLVKKLDQQASSIS 
ALSTWKDHLKHIVWPGEADSVPKGWQIPTKGKKLRIGVPKRTGYTDLVKVTRDPITNSTV 
VTGFCIDFFEAVIRELPYDVSYEFIPFEKPDGKTAGNYNDLVYQVYLGRYDAVVGDTTIL 
VNRSSYVDFTFPFIKSGVGLIVEMTDPVKRDYILFMKPLSWKLWLTSFISFFLVGCTVWV 
LEYKRNPDFSGPPRFQASTICWFAFSTMVFAPRERVFSFWARALVIAWYFLVLVLTQSYT 
ASLASLLTSQKLNPTITSMSSLLEKGETVGYQRTSFILGKLKERGFPQSSLVPFDTAEEC 
DELLSKGPKKGGVSGAFLEIPYLRLFLGQFCNTYKMVEEPFNVDGFGFVFPIGSPLVADV 
SRAILKVAESPKAMELERAWFKKKEQSCPDPITNPDPNPSFTSRQLDIDSFLFLFVGVLL 
VCVMALGNFTYCFLAKDQVSYLDKVEMSPCSSSQQMPVKRKTQLNMSQVHDQDSL*
>AT5G48740.1 |  leucine-rich repeat family protein / protein kinase family protein 
MLFWVLLSSFCVFCFSSPDGFLSLSCGGSSYTAAYNISWVSDNDYIETGNTTTVTYAEGN 
STSSVPIRLFPDPQGRQCYKLPVRKDLSSVLIRATFVYRNYDSQNSPPAFHVSLGRRITS 
TVDLRTNDPWIEELVWPVNNDSLLLCLLAVKGRGIPVISSLEVRPLPLGSYKYSLEGSPD 
IILRRSYRINSGYTNGTIRYPSDPFDRIWDPDQSYSPFHASWSFNGLTKLNSFNITENPP 
ASVLKTARILARKESLSYTLSLHTPGDYYIILYFAGILSLSPSFSVTINDEVKQSDYTVT 
SSEAGTLYFTQKGISKLNITLRKIKFNPQVSALEVYEILQIPPEASSTTVSALKVIEQFT 
GQDLGWQDDPCTPLPWNHIECEGNRVTSLFLSKINLRSISPTFGDLLDLKTLDLHNTSLT 
GAIQNVGSLKDLQKLNLSFNQLESFGSELEDLVNLEVLDLQNNSLQGSVPETLGKLKKLR 
LLNLENNNLVGPLPQSLNITGLEVRITGNPCLSFSSISCNNVSSTIDTPQVTIPINKKQR 
KQNRIAILLGVSGGALFATFLVFVFMSIFTRRQRNKERDITRAQLKMQNWNASRIFSHKE 
IKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLSQIRHQ 
NLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAVDAAKGLDYL 
HNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTAGYLDPEY 
YSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQAGAFEIVDDIL 
KETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQLSYLAASAHTD*
>AT1G74600.1 |  pentatricopeptide (PPR) repeat-containing protein 
MNCLANESLNSLKISPFSTSRLLSSVTNFRNQLSFSSKDSSSSSAPFNPFRFFNDQSNSR 
LCNLRTTKILQAHLLRRYLLPFDVFLTKSLLSWYSNSGSMADAAKLFDTIPQPDVVSCNI 
MISGYKQHRLFEESLRFFSKMHFLGFEANEISYGSVISACSALQAPLFSELVCCHTIKMG 
YFFYEVVESALIDVFSKNLRFEDAYKVFRDSLSANVYCWNTIIAGALRNQNYGAVFDLFH 
EMCVGFQKPDSYTYSSVLAACASLEKLRFGKVVQARVIKCGAEDVFVCTAIVDLYAKCGH 
MAEAMEVFSRIPNPSVVSWTVMLSGYTKSNDAFSALEIFKEMRHSGVEINNCTVTSVISA 
CGRPSMVCEASQVHAWVFKSGFYLDSSVAAALISMYSKSGDIDLSEQVFEDLDDIQRQNI 
VNVMITSFSQSKKPGKAIRLFTRMLQEGLRTDEFSVCSLLSVLDCLNLGKQVHGYTLKSG 
LVLDLTVGSSLFTLYSKCGSLEESYKLFQGIPFKDNACWASMISGFNEYGYLREAIGLFS 
EMLDDGTSPDESTLAAVLTVCSSHPSLPRGKEIHGYTLRAGIDKGMDLGSALVNMYSKCG 
SLKLARQVYDRLPELDPVSCSSLISGYSQHGLIQDGFLLFRDMVMSGFTMDSFAISSILK 
AAALSDESSLGAQVHAYITKIGLCTEPSVGSSLLTMYSKFGSIDDCCKAFSQINGPDLIA 
WTALIASYAQHGKANEALQVYNLMKEKGFKPDKVTFVGVLSACSHGGLVEESYFHLNSMV 
KDYGIEPENRHYVCMVDALGRSGRLREAESFINNMHIKPDALVWGTLLAACKIHGEVELG 
KVAAKKAIELEPSDAGAYISLSNILAEVGEWDEVEETRKLMKGTGVQKEPGWSSV*